|
Synonyms: AVI-8122 | Compound 9 [WO2023235970]
Compound class:
Synthetic organic
Comment: AVI8122 is a covalent coronavirus main protease (Mpro; 3CLpro) inhibitor, with broad spectrum activity against coronavirus genera that are found in multiple animal species, and potential to prevent zoonotic coronavirus spillover [1-2]. The ligand forms a covalent bond with the catalytic cysteine in the Mpro active site.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| AVI8122 protects against lethal SARS-CoV-2 infection in mouse models [1]. It retains activity against Mpro enzymes from coronaviruses from the four established genera (α, β, γ and δ). AVI8122 has weaker inhibitory potency against the human cathepsin S, B and L proteases (IC50 values 1.6 μM, 3.5 μM and 1.4 μM respectively), compared to nM IC50s for Mpros. |
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||